ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Risk Signature Related to Immunotherapy Reaction of Hepatocellular Carcinoma Based on the Immune-Related Genes Associated With CD8+ T Cell Infiltration

Zou, Yiping; Chen, Zhihong; Han, Hongwei; Ruan, Shiye; Jin, Liang; Zhang, Yuanpeng; Chen, Zhengrong; Ma, Zuyi; Lou, Qi; Shi, Ning*; Jin, Haosheng*广东省人民医院; 南方医科大学; 汕头大学
Frontiers in Molecular Biosciences2021-3-19DOI: 10.3389/fmolb.2021.602227
3被引6阅读
引用收藏
分享

摘要

Background: Hepatocellular carcinoma (HCC) is the most common histological type of liver cancer, with an unsatisfactory long-term survival rate. Despite immune checkpoint inhibitors for HCC have got glories in recent clinical trials, the relatively low response rate is still a thorny problem. Therefore, there is an urgent need to screen biomarkers of HCC to predict the prognosis and efficacy of immunotherapy. @@@ Methods: Gene expression profiles of HCC were retrieved from TCGA, GEO, and ICGC databases while the immune-related genes (IRGs) were retrieved from the ImmPort database. CIBERSORT and WGCNA algorithms were combined to identify the gene module most related to CD8(+) T cells in the GEO cohort. Subsequently, the genes in hub modules were subjected to univariate, LASSO, and multivariate Cox regression analyses in the TCGA cohort to develop a risk signature. Afterward, the accuracy of the risk signature was validated by the ICGC cohort, and its relationships with CD8(+) T cell infiltration and PDL1 expression were explored. @@@ Results: Nine IRGs were finally incorporated into a risk signature. Patients in the high-risk group had a poorer prognosis than those in the low-risk group. Confirmed by TCGA and ICGC cohorts, the risk signature possessed a relatively high accuracy. Additionally, the risk signature was demonstrated as an independent prognostic factor and closely related to the CD8(+) T cell infiltration and PDL1 expression. @@@ Conclusion: A risk signature was constructed to predict the prognosis of HCC patients and detect patients who may have a higher positive response rate to immune checkpoint inhibitors.

学科与关键词

关键词
CD8(+) T cellimmune checkpoint inhibitorsprognosisimmune-related geneshepatocellular carcinoma
相关
加载中…
  • Immune-related microRNA signature for predicting prognosis and the immune microenvironment in hepatocellular carcinoma.
    Li, Yue; He, Xiaoqin; Zhang, Xiaoyu; Xu, Yangtao; Wu, Yaogui*; Xu, Ximing*Life Sciences, 2021, 265: 118799.
  • Inflammatory Response-Related Long Non-Coding RNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
    Li, Xinyu; Zhang, Shuqiao; Zhang, Shijun; Kuang, Weihong; Tang, Chunzhi*Journal of Oncology, 2022, 2022: 9917244.被引 5
  • A Comprehensive Prognostic and Immunological Analysis of a New Three-Gene Signature in Hepatocellular Carcinoma
    Liu, Jun; Lu, Jianjun; Li, Wenli*2021, 2021: 5546032.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Molecular Biosciences
发表日期
2021-03-19
卷期
第 8 卷
页码
602227
DOI
10.3389/fmolb.2021.602227
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
Matching start up fund of Natural Science Foundation of China [8200110843]; Guangdong Medical Science and Technology Research Fund [A2018128]

作者

  • Z

    Zou, Yiping (第一作者)

    shantou univ · guangdong prov peoples hosp

  • C

    Chen, Zhihong

    shantou univ · guangdong prov peoples hosp

查看全部 11 位作者收起作者
  • H

    Han, Hongwei

    2 · southern med univ · guangdong prov peoples hosp

  • R

    Ruan, Shiye

    guangdong prov peoples hosp

  • J

    Jin, Liang

    guangdong prov peoples hosp

  • Z

    Zhang, Yuanpeng

    guangdong prov peoples hosp

  • C

    Chen, Zhengrong

    guangdong prov peoples hosp

  • M

    Ma, Zuyi

    shantou univ · guangdong prov peoples hosp

  • L

    Lou, Qi

    2 · southern med univ · guangdong prov peoples hosp

  • S

    Shi, Ning (通讯)

    guangdong prov peoples hosp

  • J

    Jin, Haosheng (通讯)

    guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417